Bioventus Inc.

Healthcare · Medical Devices · United States

Last price 14.87 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 1.25B

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Bioventus Inc., a medical device company, focuses on relieving pain and addressing musculoskeletal therapies in the United States and internationally. The company’s product portfolio includes pain treatments, which comprise various intra-articular and hyaluronic acid injections; peripheral nerve stimulation products, such as Durolane, GELSYN-3, and SUPARTZ for the treatment of knee osteoarthritis; and Stimrouter to treat chronic peripheral pain, and TalisMann provides stimulation to the targeted peripheral nerve, as well as XCELL PRP System, a ...